POS-079 14-3-3ζ:a PROTECTOR IN CISPLATIN-INDUCED ACUTE KIDNEY INJURY

Z. SUN,Q. Cai,S. Guo,H. Wu,M. Bao,X. Ding,X. Yu
DOI: https://doi.org/10.1016/j.ekir.2022.01.088
IF: 6.234
2022-01-01
Kidney International Reports
Abstract:Cisplatin is an anticancer agent marred by acute kidney injury (AKI). Limiting this adverse effect may allow the use of higher doses to improve its efficacy. Basing on our previous study verifying that exosomes from bone marrow mesenchymal stem cells (BMSCs) can promote the repair in cisplatin-induced AKI(AKI), the objective of this study was to identify a candidate that targets to alleviate CKI.
What problem does this paper attempt to address?